Fundz
Back to SEC Filings
10-QMEDIUM RiskDETERIORATING

BIOMERICA INC

biomerica.com
Filed: Apr 13, 2026 CIK: 0000073290Health Care
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-Q filing content

Biomerica Inc shows significant deterioration with negative gross margins in Q3 2026, declining revenues, substantial cash burn, and persistent operational losses despite some improvement in nine-month results. The company faces critical liquidity challenges with cash declining 44% from $2.4M to $1.3M while continuing to burn cash at unsustainable levels.

Red Flags Detected (7)

Negative gross margin of -4.5% in Q3 2026 vs positive 1.7% in Q3 2025

Cash declined 44% from $2.4M to $1.3M in 9 months

Q3 2026 revenue down 12% year-over-year to $987K

4 more red flags detected

Key Takeaways

Company generated negative gross margins in Q3 2026, indicating cost structure problems

Critical cash position with only $1.3M remaining and continued operating losses

3 more takeaways

Filing Overview

Form TypeQuarterly Report (10-Q)
Filing DateApr 13, 2026
Risk LevelMEDIUM
TrendDETERIORATING
AI Confidence85%
Red Flags7

What This Means

Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.

Quarterly Report: Interim filing with unaudited financial data for the quarter.

View Full Filing on SEC.govBrowse More Filings